ArticleNeuroImage. Clinical2019
AVRA: Automatic visual ratings of atrophy from MRI images using recurrent convolutional neural networks.
Article in NeuroImage. Clinical, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Differential response to donepezil in MRI subtypes of mild cognitive impairment.Alzheimer's research & therapy · 2023Trial
- Blood Biomarkers of Alzheimer's Disease and Patterns of Structural Brain Changes in the Community.Annals of neurology · 2026Article
- Association between automated brain volumetry and visual classification of hippocampal atrophy in MRI.Neuroimage. Reports · 2026Article
- ACPC-MAP: a protocol for manually aligning structural T1-weighted magnetic resonance images to the anterior commissure - posterior commissure plane according to clinical standards.Brain structure & function · 2026Article
- Structural MRI phenotyping in Alzheimer's disease: Comparison of visual rating scales, volumetry, and cortical thickness in a Serbian single-centre cohort.Biomolecules & biomedicine · 2026Article
- Frontal Lobe and Subregional Volumetric Alterations Across Alzheimer's Disease, Amnestic Mild Cognitive Impairment, and Vascular Dementia: An MRI Volumetry Study.Brain sciences · 2026Article
- Anatomical Determinants of STN Coordinate Shift in Idiopathic Parkinson's Disease DBS Surgery.CNS neuroscience & therapeutics · 2025Article
- Cerebrovascular co-pathology and cholinergic white matter pathways along the Lewy body continuum.Brain communications · 2025Article
- Evaluation of a multimodal diagnostic algorithm for prediction of cognitive impairment in elderly patients with dizziness.Journal of neurology · 2024Article
- The role of visual rating and automated brain volumetry in early detection and differential diagnosis of Alzheimer's disease.CNS neuroscience & therapeutics · 2024Article
- Regional MRI volumetry using NeuroQuant versus visual rating scales in patients with cognitive impairment and dementia.Brain and behavior · 2024Article
- Cerebrovascular and Alzheimer's disease biomarkers in dementia with Lewy bodies and other dementias.Brain communications · 2024Article
- A comprehensive review of machine learning algorithms and their application in geriatric medicine: present and future.Aging clinical and experimental research · 2023Review
- Behavioral variant frontotemporal dementia in patients with primary psychiatric disorder: A magnetic resonance imaging study.Brain and behavior · 2023Article
- Small Vessel Disease, a Marker of Brain Health: What the Radiologist Needs to Know.AJNR. American journal of neuroradiology · 2022Review
- Inter-modality assessment of medial temporal lobe atrophy in a non-demented population: application of a visual rating scale template across radiologists with varying clinical experience.European radiology · 2022Article
- Inter-Cohort Validation of SuStaIn Model for Alzheimer's Disease.Frontiers in big data · 2021Article
- Comparison of subtyping methods for neuroimaging studies in Alzheimer's disease: a call for harmonization.Brain communications · 2020Article
- Medial temporal atrophy in preclinical dementia: Visual and automated assessment during six year follow-up.NeuroImage. Clinical · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Quantifying the degree of atrophy is done clinically by neuroradiologists following established visual rating scales. For these assessments to be reliable the rater requires substantial training and experience, and even then the rating agreement between two radiologists is not perfect. We have developed a model we call AVRA (Automatic Visual Ratings of Atrophy) based on machine learning methods and trained on 2350 visual ratings made by an experienced neuroradiologist. It provides fast and automatic ratings for Scheltens' scale of medial temporal atrophy (MTA), the frontal subscale of Pasquier's Global Cortical Atrophy (GCA-F) scale, and Koedam's scale of Posterior Atrophy (PA). We demonstrate substantial inter-rater agreement between AVRA's and a neuroradiologist ratings with Cohen's weighted kappa values of κ
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.